Stocks and Investing Stocks and Investing
Wed, December 9, 2020
Tue, December 8, 2020

Brian Abrahams Maintained (VRTX) at Buy and Held Target at $265 on, Dec 8th, 2020


Published on 2024-10-27 14:57:20 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $265 on, Dec 8th, 2020.

Brian has made no other calls on VRTX in the last 4 months.



There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $257 on, Friday, October 30th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $249 on, Monday, October 19th, 2020


These are the ratings of the 6 analyists that currently disagree with Brian


  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, November 20th, 2020
  • Vincent Chen of "Bernstein" Initiated at Buy and Held Target at $275 on, Friday, November 20th, 2020
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $277 on, Friday, October 30th, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $285 on, Friday, October 30th, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $307 on, Friday, October 30th, 2020
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $305 on, Thursday, October 15th, 2020
Contributing Sources